ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Ovarian Cancer

Breast Cancer trials near Hanyang, Seoul, KOR:

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer (DB-07)

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Seoul, Korea, Republic of and 71 other locations

The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Elacestrant
Drug: Everolimus

Phase 1, Phase 2

Stemline Therapeutics
Stemline Therapeutics

Seoul, Korea, Republic of and 116 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Seoul, Korea, Republic of and 63 other locations

DESTINY-Breast 08 will investigate the safety, tolerability, PK and preliminary anti-tumour activity of T-DXd in combination with other ther ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Durvalumab

Phase 1

AstraZeneca
AstraZeneca

Seoul, Korea, Republic of and 36 other locations

endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...

Enrolling
Breast Cancer
Drug: Elacestrant
Drug: Tamoxifen

Phase 3

Stemline Therapeutics
Stemline Therapeutics

Seoul, Seoul Teugbyeolsi [Seoul-T'ukpyolshi], Korea, Republic of and 86 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

Seoul, Seoul Teugbyeolsi, Korea, Republic of and 64 other locations

ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical pra...

Not yet enrolling
Early Breast Cancer
Drug: Goserelin
Drug: Ansastrozole

Phase 3

Novartis
Novartis

Seoul, Korea, Republic of and 5 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Seoul, Korea, Republic of and 226 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Seoul, Korea, Republic of and 145 other locations

To compare and evaluate the efficacy and safety of Liporaxel® solution (oral paclitaxel) and Taxol® (IV paclitaxel) on recurrent or metastatic breast...

Active, not recruiting
Recurrent or Metastatic Breast Cancer
Drug: Oral paclitaxel
Drug: Paclitaxel injection

Phase 2, Phase 3

Daehwa Pharmaceutical

Seoul, Korea, Republic of and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems